Feature Channels:


Add to Favorites Subscribe Share

Showing results

5160 of 1175
Newswise: New Experimental Red Tide Respiratory Forecast Will Help Public Know Their Risks When They Visit the Beach

Article ID: 703208

New Experimental Red Tide Respiratory Forecast Will Help Public Know Their Risks When They Visit the Beach

Gulf of Mexico Coastal Ocean Observing System-Regional Association (GCOOS-RA)

Pinellas County residents and visitors who are susceptible to the respiratory impacts of Florida's red tide -- especially people with asthma and other chronic lung diseases -- now have a new tool that will help them know their risks before they visit area beaches during red tides.

3-Dec-2018 12:05 PM EST

Article ID: 704689

Altered microbiome after caesarean section impacts baby's immune system

University of Luxembourg

Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother's gut are passed on to the baby and stimulate the baby's immune responses. This transmission is impacted in children born by caesarean section.

30-Nov-2018 11:45 AM EST

Article ID: 704601

Functional Nasal Surgery Relieves Chronic Headache for Some Patients

Wolters Kluwer Health: Lippincott Williams and Wilkins

Nasal surgery to relieve obstructed breathing can reduce or eliminate chronic headaches in selected patients, reports a paper in the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

29-Nov-2018 10:00 AM EST
  • Embargo expired:
    27-Nov-2018 7:00 AM EST

Article ID: 704349

Electrical stimulation in the nose induces sense of smell in human subjects

Massachusetts Eye and Ear

Physicians at Massachusetts Eye and Ear have, for the first time, induced a sense of smell in humans by using electrodes in the nose to stimulate nerves in the olfactory bulb, a structure in the brain where smell information from the nose is processed and sent to deeper regions of brain. Reporting online today in International Forum of Allergy & Rhinology, the research team describes their results, which provide a proof of concept for efforts to develop implant technology to return the sense of smell to those who have lost it.

27-Nov-2018 7:00 AM EST

Article ID: 704336

Rush Opens Chicago’s First Center for Airway Diseases

Rush University Medical Center

Rush University Medical Center has opened a center for airway diseases, a comprehensive program to treat people with interrelated chronic conditions such as sinusitis, allergies, asthma and sleep apnea, which affect millions of people. It is the first program of its kind in Illinois.

26-Nov-2018 6:30 AM EST
Newswise: Peanut Allergy Immunotherapy Shows Positive Results in Phase 3 Trial

Article ID: 704266

Peanut Allergy Immunotherapy Shows Positive Results in Phase 3 Trial

Ann and Robert H. Lurie Children's Hospital of Chicago

About a year after receiving daily oral immunotherapy for severe peanut allergy, 67 percent of children in a Phase 3 trial were able to tolerate eating at least two peanuts (600 mg) without an allergic reaction, while 50 percent tolerated eating three to four peanuts (1,000 mg) without symptoms. At the start of the study, all of these children had allergic reactions after ingesting just 1/10 of a peanut (30 mg). These results of an international, randomized, double-blind, placebo-controlled trial conducted at 66 sites, including Ann & Robert H. Lurie Children’s Hospital of Chicago, were published in the New England Journal of Medicine.

20-Nov-2018 10:50 AM EST
New Logo.png

Article ID: 704204

Researchers find promise in new treatment for peanut allergy

University of Chicago Medical Center

Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine say an oral immunotherapy drug they tested could be the first FDA-approved medication of its kind for people with peanut allergy. The medication, called AR101, is derived from peanut protein.

19-Nov-2018 11:05 AM EST
Newswise: Researchers discover how 'cryptic' connections in disease transmission influence epidemics
  • Embargo expired:
    19-Nov-2018 11:00 AM EST

Article ID: 704117

Researchers discover how 'cryptic' connections in disease transmission influence epidemics

Virginia Tech

A new study by researchers of disease transmission in bats has broad implications for understanding hidden connections that can spread diseases between species and lead to large-scale outbreaks.

16-Nov-2018 10:05 AM EST

Showing results

5160 of 1175

Chat now!